The global apolipoprotein test market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of cardiovascular diseases and other related disorders, which are major causes for apolipoprotein testing. Moreover, the increasing number of research studies on apolipoproteins and their role in various diseases will also drive the growth of this market. The global apolipoprotein test market by type includes ELISA kit, immunseparation reagent kit, and immunoassay kit. The ELISA kits segment accounted for a significant share in 2017 owing to its high accuracy level and low cost-effectiveness as compared with other types such as immunoassay kits or immunseparation reagent kits. However, due to its high cost-effectiveness and wide range of applications in various fields such as clinical diagnostics or research purposes, the demand for immunoassay kits is expected to increase significantly during the forecast period from 2021-2030. The global apolipoprotein test market by application includes hospital (including clinics), clinic (including research institutions), and others (such as home care). The hospital segment accounted for a significant share in 2017 owing to its higher prevalence rates among patients with cardiovascular diseases or other related disorders that require frequent monitoring through blood tests such as lipid profile tests or cholesterol levels tests; however it is expected that this segment will decline over time due to an increase in home care services offered by private healthcare providers who offer more affordable treatment options than hospitals do.
- The Apolipoprotein Test market is driven by the increasing prevalence of cardiovascular diseases and diabetes.
- Increasing awareness about the importance of lipid profile in diagnosing cardiovascular diseases and diabetes.
- Increasing number of clinical trials for new drugs that target lipid profiles.
- Increase in government funding for research on lipid profiles.
Industry Growth Insights published a new data on “Apolipoprotein Test Market”. The research report is titled “Apolipoprotein Test Market research by Types (ELISA Kit, Immuno-separation Reagent Kit, Immunoassay Kit), By Applications (Hospital, Clinic, Research Institution, Other, ), By Players/Companies Randox Laboratories, Abbott Laboratories, Bio-Rad Laboratories, OPKO Health, Myriad Genetics, Quest Diagnostics, Eurofins Scientific, Lincoln Diagnostics, DiaSorin, Boster Biological Technology, Rockland Immunochemicals, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Apolipoprotein Test Market Research Report
By Type
ELISA Kit, Immuno-separation Reagent Kit, Immunoassay Kit
By Application
Hospital, Clinic, Research Institution, Other,
By Companies
Randox Laboratories, Abbott Laboratories, Bio-Rad Laboratories, OPKO Health, Myriad Genetics, Quest Diagnostics, Eurofins Scientific, Lincoln Diagnostics, DiaSorin, Boster Biological Technology, Rockland Immunochemicals,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Apolipoprotein Test Market Report Segments:
The global Apolipoprotein Test market is segmented on the basis of:
Types
ELISA Kit, Immuno-separation Reagent Kit, Immunoassay Kit
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Research Institution, Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Randox Laboratories
- Abbott Laboratories
- Bio-Rad Laboratories
- OPKO Health
- Myriad Genetics
- Quest Diagnostics
- Eurofins Scientific
- Lincoln Diagnostics
- DiaSorin
- Boster Biological Technology
- Rockland Immunochemicals
Highlights of The Apolipoprotein Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ELISA Kit
- Immuno-separation Reagent Kit
- Immunoassay Kit
- By Application:
- Hospital
- Clinic
- Research Institution
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Apolipoprotein Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The apolipoprotein test is a blood test that measures the level of apolipoprotein A-1 and apolipoprotein B in your blood. Apolipoproteins are proteins that play a role in cholesterol metabolism.
Some of the key players operating in the apolipoprotein test market are Randox Laboratories, Abbott Laboratories, Bio-Rad Laboratories, OPKO Health, Myriad Genetics, Quest Diagnostics, Eurofins Scientific, Lincoln Diagnostics, DiaSorin, Boster Biological Technology, Rockland Immunochemicals.
The apolipoprotein test market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Apolipoprotein Test Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Apolipoprotein Test Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Apolipoprotein Test Market - Supply Chain
4.5. Global Apolipoprotein Test Market Forecast
4.5.1. Apolipoprotein Test Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Apolipoprotein Test Market Size (000 Units) and Y-o-Y Growth
4.5.3. Apolipoprotein Test Market Absolute $ Opportunity
5. Global Apolipoprotein Test Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Apolipoprotein Test Market Size and Volume Forecast by Type
5.3.1. ELISA Kit
5.3.2. Immuno-separation Reagent Kit
5.3.3. Immunoassay Kit
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Apolipoprotein Test Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Apolipoprotein Test Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Research Institution
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Apolipoprotein Test Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Apolipoprotein Test Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Apolipoprotein Test Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Apolipoprotein Test Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Apolipoprotein Test Demand Share Forecast, 2019-2026
9. North America Apolipoprotein Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Apolipoprotein Test Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Apolipoprotein Test Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Research Institution
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Apolipoprotein Test Market Size and Volume Forecast by Type
9.7.1. ELISA Kit
9.7.2. Immuno-separation Reagent Kit
9.7.3. Immunoassay Kit
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Apolipoprotein Test Demand Share Forecast, 2019-2026
10. Latin America Apolipoprotein Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Apolipoprotein Test Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Apolipoprotein Test Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Research Institution
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Apolipoprotein Test Market Size and Volume Forecast by Type
10.7.1. ELISA Kit
10.7.2. Immuno-separation Reagent Kit
10.7.3. Immunoassay Kit
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Apolipoprotein Test Demand Share Forecast, 2019-2026
11. Europe Apolipoprotein Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Apolipoprotein Test Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Apolipoprotein Test Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Research Institution
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Apolipoprotein Test Market Size and Volume Forecast by Type
11.7.1. ELISA Kit
11.7.2. Immuno-separation Reagent Kit
11.7.3. Immunoassay Kit
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projectionsby Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Apolipoprotein Test Demand Share, 2019-2026
12. Asia Pacific Apolipoprotein Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Apolipoprotein Test Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Apolipoprotein Test Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Research Institution
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Apolipoprotein Test Market Size and Volume Forecast by Type
12.7.1. ELISA Kit
12.7.2. Immuno-separation Reagent Kit
12.7.3. Immunoassay Kit
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Apolipoprotein Test Demand Share, 2019-2026
13. Middle East & Africa Apolipoprotein Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Apolipoprotein Test Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Apolipoprotein Test Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Research Institution
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Apolipoprotein Test Market Size and Volume Forecast by Type
13.7.1. ELISA Kit
13.7.2. Immuno-separation Reagent Kit
13.7.3. Immunoassay Kit
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Apolipoprotein Test Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Apolipoprotein Test Market: Market Share Analysis
14.2. Apolipoprotein Test Distributors and Customers
14.3. Apolipoprotein Test Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Randox Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Rad Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. OPKO Health
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Myriad Genetics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Quest Diagnostics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Eurofins Scientific
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Lincoln Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. DiaSorin
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Boster Biological Technology
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Rockland Immunochemicals
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook